| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $0 ) |
| | 2026 | 2025 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43DA062234 | Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder | 000 | 1 | NIH | 11/20/2025 | $0 |
|
| Issue Date FY: 2025 ( Subtotal = $310,114 ) |
| | 2025 | 2025 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43DA062234 | Development of a Medication Adherence and Monitoring System Supporting Decentralized Clinical Trials for Substance Use Disorder | 000 | 1 | NIH | 7/17/2025 | $306,528 |
| | 2025 | 2025 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43DA060717 | Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients | 000 | 1 | NIH | 5/30/2025 | $6,500 |
| | 2025 | 2024 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43DA060717 | Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients | 001 | 1 | NIH | 8/13/2025 | $0 |
| | 2025 | 2022 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 05 | 1 | CDC | 5/6/2025 | -$2,914 |
|
| Issue Date FY: 2024 ( Subtotal = $295,906 ) |
| | 2024 | 2024 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43DA060717 | Integration of an opioid dispensing, monitoring, and disposal platform with a hospital pharmacy to reduce opioid use by discharged emergency department patients | 000 | 1 | NIH | 9/5/2024 | $295,906 |
| | 2024 | 2022 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 03 | 1 | CDC | 5/10/2024 | $0 |
| | 2024 | 2022 | ADDINEX TECHNOLOGIES, INC. | 11 RIVERSIDE DRIVE, 7WE | NEW YORK | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 04 | 1 | CDC | 6/7/2024 | $0 |
|
| Issue Date FY: 2023 ( Subtotal = $0 ) |
| | 2023 | 2022 | Addinex Technologies, Inc. | 11 Riverside Dr Ste 7WE | New York | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 01 | 1 | CDC | 3/17/2023 | $0 |
| | 2023 | 2022 | Addinex Technologies, Inc. | 11 Riverside Dr Ste 7WE | New York | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 02 | 1 | CDC | 6/14/2023 | $0 |
|
| Issue Date FY: 2022 ( Subtotal = $259,559 ) |
| | 2022 | 2022 | ADDINEX TECHNOLOGIES, INC. | 11 Riverside Dr Ste 7WE | New York | NY | 10023-1338 | NEW YORK | USA | R43CE003533 | Development of a telehealth medication-assisted treatment (MAT) system for patients with opioid use disorder (OUD) | 00 | 1 | CDC | 8/19/2022 | $259,559 |
|
|
